THE IMPACT OF TIMING OF ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY ON TREATMENT OUTCOMES OF ACUTE PANCREATITIS DUE TO CHOLEDOCHOLITHIASIS
Main Article Content
Abstract
Background: Choledocholithiasis (common bile duct stones) is one of the leading causes of acute pancreatitis, with a high rate of severe progression and mortality. The combination of medical treatment and endoscopic retrograde cholangiopancreatography (ERCP) has contributed to reducing mortality rates. However, the optimal timing for ERCP remains controversial in optimizing treatment outcomes. Objectives: To describe the clinical and subclinical characteristics of patients with acute pancreatitis caused by choledocholithiasis and evaluate the impact of ERCP timing on the treatment outcomes of acute pancreatitis due to choledocholithiasis. Materials and methods: A prospective cross-sectional study was conducted on 53 patients diagnosed with acute pancreatitis due to choledocholithiasis who underwent ERCP at Can Tho Central General Hospital from January 2024 to February 2025. Results: The mean age of patients was 63.8 ± 19.4 years, with 63.5% being 60 years or older. Female patients accounted for 74%, approximately three times the number of male patients. Abdominal pain was present in all patients (100%). The rate of acute pancreatitis with concomitant cholangitis was 45.3%. The overall success rate of ERCP was 98.1%. Early ERCP intervention within 24 hours significantly improved clinical symptoms (p<0.001). ERCP performed within 48 hours reduced hospital stay duration (p=0.008) and facilitated earlier symptom resolution (p=0.005). Post-ERCP complication rate was 3.8%. Conclusion: Early ERCP intervention within the first 48 hours for acute pancreatitis due to choledocholithiasis helps improve clinical symptoms and reduces hospital stay duration. ERCP is an effective treatment modality with a high success rate and a low complication rate.
Article Details
Keywords
Endoscopic retrograde cholangiopancreatography, acute pancreatitis, choledocholithiasis
References
2. Nguyễn Đình Hối và cộng sự (2012), "Sỏi đường mật", Nhà xuất bản Y học.
3. Thái Doãn Kỳ và cộng sự (2023), "Đánh giá hiệu quả và an toàn của phương pháp nội soi mật tụy ngược dòng điều trị sỏi đường mật tại Bệnh viện Trung ương Quân đội 108", Journal of 108-Clinical Medicine Phamarcy.
4. Hoàng Thuý Nga và cộng sự (2023), "Nguyên nhân và một số yếu tố tiên lượng bệnh nhân viêm tụy cấp tại Bệnh viện Đại học Y Hà Nội". 169(8), tr. 139-146.
5. Dương Minh Thắng và cộng sự (2019), "Kết quả nội soi mật tụy ngược dòng cấp cứu điều trị viêm đường mật và viêm tụy cấp thể phù nề do sỏi ống mật chủ", Journal of 108-Clinical Medicine.
6. Ding Songming et al (2021), "Factors related to the spontaneous passage of common bile duct stones through the papilla: a single-center retrospective cohort study", Journal of International Medical Research. 49(11), tr. 03000605211058381.
7. Dumonceau Jean-Marc et al (2020), "ERCP-related adverse events: European Society of Gastrointestinal Endoscopy (ESGE) guideline", Endoscopy. 52(02), tr. 127-149.
8. İnan Bayram et al (2024), "Assessment of The Factors Related to The Spontaneous Passage of Common Bile Duct Stones", Journal of Clinical Medicine. 13(9), tr. 2672.
9. Iqbal Umair et al (2020), "Emergent versus urgent ERCP in acute cholangitis: a systematic review and meta-analysis", Gastrointestinal endoscopy. 91(4), tr. 753-760.
10. Schepers Nicolien J et al (2016), "Early biliary decompression versus conservative treatment in acute biliary pancreatitis (APEC trial): study protocol for a randomized controlled trial", Trials. 17, tr. 1-10.